Variant 12-49043616-T-G details in Genebe, Genetics Data Aggregator

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_003482.4(KMT2D):c.5467+19A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0272 in 1,613,334 control chromosomes in the GnomAD database, including 736 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.024 ( 73 hom., cov: 32)

Exomes 𝑓: 0.028 ( 663 hom. )

Consequence

KMT2D
NM_003482.4 intron

Scores

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.190

Variant links:

Genes affected

KMT2D (HGNC:7133): (lysine methyltransferase 2D) The protein encoded by this gene is a histone methyltransferase that methylates the Lys-4 position of histone H3. The encoded protein is part of a large protein complex called ASCOM, which has been shown to be a transcriptional regulator of the beta-globin and estrogen receptor genes. Mutations in this gene have been shown to be a cause of Kabuki syndrome. [provided by RefSeq, Oct 2010]

KMT2D links:

KMT2D (HGNC:):

KMT2D links:

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4

Computational evidence support a benign effect (BayesDel_noAF=-0.93).

BP6

Variant 12-49043616-T-G is Benign according to our data. Variant chr12-49043616-T-G is described in ClinVar as [Benign]. Clinvar id is 94228.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-49043616-T-G is described in Lovd as [Benign].

BS1

Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0242 (3692/152280) while in subpopulation NFE AF= 0.0345 (2347/68016). AF 95% confidence interval is 0.0333. There are 73 homozygotes in gnomad4. There are 1821 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.

BS2

High AC in GnomAd4 at 3692 AD gene.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	Protein	UniProt
KMT2D	NM_003482.4 linkuse as main transcript	c.5467+19A>C		intron_variant		ENST00000301067.12	NP_003473.3	O14686-1Q59FG6Q6PIA1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Protein	Appris	UniProt
KMT2D	ENST00000301067.12 linkuse as main transcript	c.5467+19A>C		intron_variant		5	NM_003482.4	ENSP00000301067.7		O14686-1

Frequencies

GnomAD3 genomes

AF:

0.0243

AC:

3692

AN:

152162

Hom.:

Cov.:

show subpopulations

Gnomad AFR

AF:

0.00442

Gnomad AMI

AF:

0.0241

Gnomad AMR

AF:

0.0209

Gnomad ASJ

AF:

0.0236

Gnomad EAS

AF:

0.000385

Gnomad SAS

AF:

0.0215

Gnomad FIN

AF:

0.0543

Gnomad MID

AF:

0.0285

Gnomad NFE

AF:

0.0345

Gnomad OTH

AF:

0.0230

GnomAD3 exomes

AF:

0.0259

AC:

6424

AN:

248410

Hom.:

103

AF XY:

0.0262

AC XY:

3537

AN XY:

134788

show subpopulations

Gnomad AFR exome

AF:

0.00395

Gnomad AMR exome

AF:

0.0166

Gnomad ASJ exome

AF:

0.0208

Gnomad EAS exome

AF:

0.000112

Gnomad SAS exome

AF:

0.0249

Gnomad FIN exome

AF:

0.0483

Gnomad NFE exome

AF:

0.0321

Gnomad OTH exome

AF:

0.0285

GnomAD4 exome

AF:

0.0275

AC:

40213

AN:

1461054

Hom.:

663

Cov.:

AF XY:

0.0275

AC XY:

19974

AN XY:

726812

show subpopulations

Gnomad4 AFR exome

AF:

0.00388

Gnomad4 AMR exome

AF:

0.0169

Gnomad4 ASJ exome

AF:

0.0219

Gnomad4 EAS exome

AF:

0.000151

Gnomad4 SAS exome

AF:

0.0251

Gnomad4 FIN exome

AF:

0.0466

Gnomad4 NFE exome

AF:

0.0292

Gnomad4 OTH exome

AF:

0.0258

GnomAD4 genome

AF:

0.0242

AC:

3692

AN:

152280

Hom.:

Cov.:

AF XY:

0.0245

AC XY:

1821

AN XY:

74442

show subpopulations

Gnomad4 AFR

AF:

0.00445

Gnomad4 AMR

AF:

0.0209

Gnomad4 ASJ

AF:

0.0236

Gnomad4 EAS

AF:

0.000386

Gnomad4 SAS

AF:

0.0215

Gnomad4 FIN

AF:

0.0543

Gnomad4 NFE

AF:

0.0345

Gnomad4 OTH

AF:

0.0227

Alfa

AF:

0.0341

Hom.:

Bravo

AF:

0.0196

Asia WGS

AF:

0.0120

AC:

AN:

3478

ClinVar

Significance: Benign

Submissions summary: Benign:5

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

not specified

Benign:3

Benign, criteria provided, single submitter	clinical testing	Eurofins Ntd Llc (ga)	Jul 06, 2012	- -
Benign, criteria provided, single submitter	clinical testing	PreventionGenetics, part of Exact Sciences	-	- -
Benign, criteria provided, single submitter	clinical testing	GeneDx	Nov 20, 2017	This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Kabuki syndrome

Benign:1

Benign, criteria provided, single submitter

clinical testing

Labcorp Genetics (formerly Invitae), Labcorp

Feb 01, 2024

- -

not provided

Benign:1

Benign, criteria provided, single submitter

not provided

Breakthrough Genomics, Breakthrough Genomics

- -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_noAF

Benign

-0.93

CADD

Benign

7.4

DANN

Benign

0.63

RBP_binding_hub_radar

0.0

RBP_regulation_power_radar

1.1

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

LitVar

Other links and lift over